Other Vaccines - Bangladesh

Bangladesh

Highlights

The projected revenue in the Other Vaccines market for Bangladesh is expected to reach US$34.23m in 2024.
It is estimated that the revenue will show an annual growth rate (CAGR 2024-2029) of 11.93%, leading to a market volume of US$60.14m by 2029.
When compared globally, it is anticipated that United States will generate the highest revenue, amounting to US$24.73bn in 2024.
Bangladesh is experiencing a growing demand for other vaccines due to increasing awareness about the importance of immunization.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other Vaccines market in Bangladesh has been experiencing significant growth in recent years.

Customer preferences: Bangladesh has a large population with a high demand for healthcare services. As such, there is a growing demand for vaccines to prevent various illnesses. Additionally, the government has been working to increase awareness about the importance of vaccination, leading to more people seeking out vaccination services.

Trends in the market: One of the key trends in the Other Vaccines market in Bangladesh is the increasing availability of vaccines. Many international pharmaceutical companies have been expanding their operations in the country, leading to a wider range of vaccines being available. This has also led to increased competition in the market, which has helped to drive down prices.Another trend in the market is the growing popularity of combination vaccines. These vaccines offer protection against multiple diseases in a single shot, making them more convenient for patients and healthcare providers. As a result, demand for combination vaccines has been increasing in Bangladesh.

Local special circumstances: One of the unique factors affecting the Other Vaccines market in Bangladesh is the country's geography. Bangladesh is prone to natural disasters such as floods and cyclones, which can lead to the spread of diseases such as cholera. As a result, there is a high demand for vaccines to prevent these types of illnesses.Additionally, Bangladesh has a large population of migrant workers who may be at higher risk of contracting certain diseases. This has led to a demand for vaccines that are specific to the needs of this population.

Underlying macroeconomic factors: Bangladesh has been experiencing strong economic growth in recent years, which has helped to drive demand for healthcare services, including vaccines. Additionally, the government has been investing in the healthcare sector, which has helped to improve access to vaccines for the population.Overall, the Other Vaccines market in Bangladesh is poised for continued growth in the coming years. As the government continues to invest in the healthcare sector and demand for vaccines remains strong, international pharmaceutical companies are likely to continue expanding their operations in the country.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.